Amplia

Be first to know our latest company updates

Watch exclusive videos accompanying major news

Contact

Board

Company Overview

Team

Corporate Governance

Corporate Directory

Values

Clinical Advisers

About Us

Video Updates

Presentations

In the News

Communication

Updates

US Shareholders

Investor FAQs

Shareholder Services

Research Reports

Reports

Announcements

Investor Fact Sheet

Top 20 Shareholders

Share Price

Investor Centre

Clinical Trial

Webinars

Pipeline

Home

Montserrat

Amplia Therapeutics Limited

upload.jpg

Congratulations to Amplia CEO & MD, Dr Chris Burns, who has been elected as a Fellow to the Australian Academy of Health and Medical Sciences (AAHMS).

The Academy reserves this distinction for only the best and brightest minds in the field of medical and health sciences, in recognition of their outstanding achievements and exceptional contributions to the sector.

We are immensely grateful for Dr. Burns' dedication to advancing medical research and his leadership in developing innovative therapies at Amplia. This Fellowship is a well-deserved acknowledgment of his commitment to improving human health, and we look forward to his continued contributions to the field.

Dr Chris Burns elected as a Fellow to the Australian Academy of Health and Medical Sciences (AAHMS)